Evidence map›Paper›PMID 42064015›Full record

ArticleOphthalmology science2026

Patterns of X-Linked Retinitis Pigmentosa Genetic Testing in England and Implications for Service Provision.

Sol Yates, William Whittaker, Mark Harrison, Stuart Bayliss, Stephanie Barton, Panagiotis I Sergouniotis, Katherine Payne, Graeme Black

Abstract read
In one paragraph

Article in Ophthalmology science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sol YatesManchester Centre for Health Economics, Division of Population Health, Health Services Research & Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
William WhittakerPublic Health, Policy & Systems, University of Liverpool, Liverpool, UK.
Mark HarrisonFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
Stuart BaylissNorth West Genomic Medicine Service Alliance, Saint Mary's Hospital, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.
Stephanie BartonManchester Centre for Genomic Medicine, Saint Mary's Hospital, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.
Panagiotis I SergouniotisManchester Centre for Genomic Medicine, Saint Mary's Hospital, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.
Katherine PayneManchester Centre for Health Economics, Division of Population Health, Health Services Research & Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
Graeme BlackManchester Centre for Genomic Medicine, Saint Mary's Hospital, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To establish the prevalence of retinitis pigmentosa GTPase regulator ( Design: A cross-sectional prevalence study. Participants: English National Health Service patients referred for XLRP molecular testing between 2004 and 2024. Methods: We calculated the overall prevalence rate of Main Outcome Measures: Prevalence of Results: The estimated mortality-adjusted prevalence of Conclusions: We identified an estimated 977 living patients with Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Indexed as

Genetic TestingInherited retinal diseasesPopulation prevalenceRetinitis pigmentosaX-linked retinitis pigmentosa

Identifiers

PMID42064015
PMCPMC13127330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.